Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
MetadataShow full item record
BACKGROUND: Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are undefined. The relationships between patterns of mutations and epigenetic phenotypes are not yet clear. METHODS: We analyzed the genomes of 200 clinically annotated adult cases of de novo AML, using either whole-genome sequencing (50 cases) or whole-exome sequencing (150 cases), along with RNA and microRNA sequencing and DNA-methylation analysis. RESULTS: AML genomes have fewer mutations than most other adult cancers, with an average of only 13 mutations found in genes. Of these, an average of 5 are in genes that are recurrently mutated in AML. A total of 23 genes were significantly mutated, and another 237 were mutated in two or more samples. Nearly all samples had at least 1 nonsynonymous mutation in one of nine categories of genes that are almost certainly relevant for pathogenesis, including transcription-factor fusions (18% of cases), the gene encoding nucleophosmin (NPM1) (27%), tumor-suppressor genes (16%), DNA-methylation-related genes (44%), signaling genes (59%), chromatin-modifying genes (30%), myeloid transcription-factor genes (22%), cohesin-complex genes (13%), and spliceosome-complex genes (14%). Patterns of cooperation and mutual exclusivity suggested strong biologic relationships among several of the genes and categories. CONCLUSIONS: We identified at least one potential driver mutation in nearly all AML samples and found that a complex interplay of genetic events contributes to AML pathogenesis in individual patients. The databases from this study are widely available to serve as a foundation for further investigations of AML pathogenesis, classification, and risk stratification. (Funded by the National Institutes of Health.) Copyright © 2013 Massachusetts Medical Society.
Showing items related by title, author, creator and subject.
Molecular mechanism underlying aberrant expression of the connective tissue growth factor in paediatric pre-B cell acute lymphoblastic leukemiaWelch, Mathew D. (2011)Acute lymphoblastic leukaemia (ALL) is the most common cancer diagnosed in children aged 1-14 years. There have been vast improvements in clinical outcomes for children diagnosed with ALL with cure rates of up to 90% ...
Collisson, E.; Campbell, J.; Brooks, A.; Berger, A.; Lee, W.; Chmielecki, J.; Beer, D.; Cope, L.; Creighton, C.; Danilova, L.; Ding, L.; Getz, G.; Hammerman, P.; Hayes, D.; Hernandez, B.; Herman, J.; Heymach, J.; Jurisica, I.; Kucherlapati, R.; Kwiatkowski, D.; Ladanyi, M.; Robertson, G.; Schultz, N.; Shen, R.; Sinha, R.; Sougnez, C.; Tsao, M.; Travis, W.; Weinstein, J.; Wigle, D.; Wilkerson, M.; Chu, A.; Cherniack, A.; Hadjipanayis, A.; Rosenberg, M.; Weisenberger, D.; Laird, P.; Radenbaugh, A.; Ma, S.; Stuart, J.; Byers, L.; Baylin, S.; Govindan, R.; Meyerson, M.; Gabriel, S.; Cibulskis, K.; Kim, J.; Stewart, C.; Lichtenstein, L.; Lander, E.; Lawrence, M.; Getz, E.; Fulton, R.; Fulton, L.; McLellan, M.; Wilson, R.; Ye, K.; Fronick, C.; Maher, C.; Miller, C.; Wendl, M.; Cabanski, C.; Mardis, E.; Wheeler, D.; Balasundaram, M.; Butterfield, Y.; Carlsen, R.; Chuah, E.; Dhalla, N.; Guin, R.; Hirst, C.; Lee, D.; Li, H.; Mayo, M.; Moore, R.; Mungall, A.; Schein, J.; Sipahimalani, P.; Tam, A.; Varhol, Richard; Robertson, A.; Wye, N.; Thiessen, N.; Holt, R.; Jones, S.; Marra, M.; Imielinski, M.; Onofrio, R.; Hodis, E.; Zack, T.; Helman, E. (2014)Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report molecular profiling of 230 resected lung adenocarcinomas using messenger RNA, microRNA and DNA sequencing integrated with copy ...
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancersYip, S.; Butterfield, Y.; Morozova, O.; Chittaranjan, S.; Blough, M.; An, J.; Birol, I.; Chesnelong, C.; Chiu, R.; Chuah, E.; Corbett, R.; Docking, R.; Firme, M.; Hirst, M.; Jackman, S.; Karsan, A.; Li, H.; Louis, D.; Maslova, A.; Moore, R.; Moradian, A.; Mungall, K.; Perizzolo, M.; Qian, J.; Roldan, G.; Smith, E.; Tamura-Wells, J.; Thiessen, N.; Varhol, Richard; Weiss, S.; Wu, W.; Young, S.; Zhao, Y.; Mungall, A.; Jones, S.; Morin, G.; Chan, J.; Cairncross, J.; Marra, M. (2012)Oligodendroglioma is characterized by unique clinical, pathological, and genetic features. Recurrent losses of chromosomes 1p and 19q are strongly associated with this brain cancer but knowledge of the identity and function ...